A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...

A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda(R)) Lexaria has now demonstrated, in distinct ...